Is monosomy 5 an uncommon aberration? Fluorescence in situ hybridization reveals translocations and deletions in myelodysplastic syndromes or acute myelocytic leukemia

Cancer Genetics and Cytogenetics

Volumn 142, Issue 2, 2003, Pages 107-114

  Bram, Susanne ^a   Swolin, Birgitta ^a   Rödjer, Stig ^a   Stockelberg, Dick ^a   Ögärd, Inger ^a   Bäck, Hans ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b BORÅS HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; CANCER PATIENT; CHROMOSOME 5P; CHROMOSOME 5Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME BANDING PATTERN; CHROMOSOME BREAKAGE; CHROMOSOME DELETION 5; CHROMOSOME PAINTING; CHROMOSOME TRANSLOCATION 5; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE PROBE; HUMAN; HUMAN CELL; MOLECULAR CLONING; MONOSOMY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

EID: 0037446729     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00836-1     Document Type: Article

References (31)

1. Mufti G.J. Chromosomal deletions in the myelodysplastic syndrome. Leuk Res. 16:1992;35-41.
2. Haase D., Fonatsch C., Freund M., Wörman B., Bodenstein H., Bartels H., Stollmann-Gibbels B., Lengfelder E. Cytogenetic findings in 179 patients with myelodysplastic syndromes. Ann Hematol. 40:1995;171-186.
3. Solé F., Espinet B., Sanz G.F., Cervera J., Calasanz M.J., Luno E., Prieto F., Granada I., Hernandez J.M., Cruz Cigudosa J., Diez J.L., Bureo E., Marqués M.L., Arranz E., Ríos R., Martinez Climent J.A., Vallespi T., Florensa L., Woessner S. Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Br J Haematol. 108:2000;346-356.
4. Heim S. Cytogenetic findings in primary and secondary MDS. Leuk Res. 16:1992;43-46.
5. Boultwood J., Fidler C. Chromosomal deletions in myelodysplasia. Leuk Lymphoma. 17:1995;71-78.
6. Heim S., Mitelman F. Cancer cytogenetics. 2nd edition:1995;Wiley-Liss, New York.
7. Van den Berghe H., Michaux L. 5q-, twenty-five years later. a synopsis Cancer Genet Cytogenet. 94:1997;1-7.
8. Harris N.L., Jaffe E.S., Diebold J., Flandrin G., Muller-Hermelink H.K., Vardiman J., Lister T.A., Bloomfield C.D. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues. report of the clinical advisory committee meeting - Airlie House, VA, November 1997 Hematol J. 1:2000;53-66.
9. Jaffe E.S., Harris N.L., Stein H., Vardiman J.W. Myelodysplastic syndromes. World Health Organization classification of tumours. Pathology and genetics, tumours of haematopoietic and lymphoid tissues. 2001;IARC Press; Lyon. pp. 61-73.
10. Jaffe E.S., Harris N.L., Stein H., Vardiman J.W. Acute myeloid leukemia. World Health Organization classification of tumors. Pathology and genetics, tumours of haematopoietic and lymphoid tissues. 2001;IARC Press; Lyon. pp. 75-107.
11. Tanaka K., Arif M., Eguchi M., Shintani T., Kumaravel T.S., Asaoku H., Kyo T., Dohy H., Kamada N. Interphase fluorescence in situ hybridization overcomes pitfalls of G-banding analysis with special reference to underestimation of chromosomal aberrations rates. Cancer Genet Cytogenet. 115:1999;32-38.
12. Le Beau M.M., Espinosa R. III, Neuman W.L., Stock W., Roulston D., Larson R.A., Keinanan M., Westbrook C.A. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proc Natl Acad Sci USA. 90:1993;5484-5488.
13. Lessard M., Herry A., Berthou C., Chantal Leglise M., Abgrall J.F., Morice P., Flandrin G. FISH investigation of 5q and 7q deletions in MDS/AML reveals hidden translocations, insertions and fragmentations of the same chromosome. Leuk Res. 22:1998;303-312.
14. Wilkens L., Burkhardt D., Tchinda J., Busche G., Werner M., Nolte M., Ganser A., Georgii A. Cytogenetic aberrations in myelodysplastic syndrome detected by comparative genomic hybridization and fluorescence in situ hybridization. Diagn Mol Pathol. 8:1999;47-53.
15. Brezinová J., Zemanová Z., Cermák J., Michalová K. Fluorescence in situ hybridization confirmation of 5q deletions in patients with hematological malignancies. Cancer Genet Cytogenet. 117:2000;45-49.
16. Van Limbergen H., Poppe B., Michaux L., Herens C., Brown J., Noens L., Berneman Z., De Bock R., De Paepe A., Speleman F. Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH. Genes Chromosomes Cancer. 33:2002;60-72.
17. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A.G., Gralnick H.R., Sultan C. Proposals for the classification of the acute leukemias. Br J Haematol. 33:1976;451-458.
18. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A.G., Gralnick H.R., Sultan C. Proposals for the classification of the myelodysplastic syndromes. French-American-British (FAB) co-operative group Br J Haematol. 51:1982;189-199.
19. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A.G., Gralnick H.R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med. 103:1985;620-625.
20. ISCN. An international system for human cytogenetic nomenclature. Mitelman, F, editor. Basel: S. Karger, 1995.
21. Le Beau M. Deletions of chromosome 5 in malignant myeloid disorders. Cancer Surv. 15:1992;143-159.
22. Fairman J., Wang R.Y., Liang H., Zhao L., Saltman D., Liang J.C., Nagarajan L. Translocations and deletions of 5q13.1 in myelodysplasia and acute myelogenous leukemia. evidence for a novel critical locus Blood. 88:1996;2259-2266.
23. Boultwood J., Lewis S., Wainscoat J.S. The 5q- syndrome. Blood. 84:1994;3253-3260.
24. Ning Y., Liang J.C., Nagarajan L., Schröck E., Ried T. Characterization of 5 q deletions by subtelomeric probes and spectral karyotyping. Cancer Genet Cytogenet. 103:1998;170-172.
25. Tigaud I., Charrin C., Berger R., Jonveaux P. Partial deletion of the long arm of chromosome 5. a fluorescence in situ hybridization study using band-specific painting probes generated by chromosome microdissection Cancer Genet Cytogenet. 89:1996;126-128.
26. Veldman T., Vignon C., Schröck E., Rowley J.D., Ried T. Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping. Nat Genet. 15:1997;406-410.
27. Mohr B., Bornhäuser M., Thiede C., Schäkel U., Schaich M., Illmer T., Pascheberg U., Ehninger G. Comparison of spectral karyotyping and conventional cytogenetics in 39 patients with acute myeloid leukemia and myelodysplastic syndrome. Leukemia. 14:2000;1031-1038.
28. Westbrook C.A., Hsu W.T., Chyna B., Litvak D., Raza A., Horrigan S.K. Cytogenetic and molecular diagnosis of chromosome 5 deletions in myelodysplasia. Br J Haematol. 110:2000;847-855.
29. Bernasconi P., Alessandrino E.P., Boni M., Bonfichi M., Morra E., Lazzarino M., Campagnoli C., Astori C. Karyotype in myelodysplastic syndromes. relations to morphology, clinical evolution, and survival Am J Hematol. 46:1994;270-277.
30. Germing U., Gattermann N., Strupp C., Aivado M., Aul C. Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes. a retrospective analysis of 1600 patients Leuk Res. 24:2000;983-992.
31. Greenberg P., Cox C., Le Beau M., Fenaux P., Morel P., Sanz G., Sanz M., Vallespi T., Hamblin T., Oscier D., Ohyashiki K., Toyama K., Aul C., Mufti G., Bennett J. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 89:1997;2079-2088.